| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 28-Feb-09 | 30-Nov-08 | | Total Revenue | 4,798,500 | 4,713,000 | 4,440,800 | 4,590,100 | | Cost of Revenue | 2,583,000 | 2,669,200 | 2,492,300 | 2,540,100 | | | Gross Profit | 2,215,500 | 2,043,800 | 1,948,500 | 2,050,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,546,100 | 1,394,300 | 1,352,100 | 1,546,800 | | Non Recurring |
-
| 195,000 | 401,300 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 669,400 | 454,500 | 195,100 | 503,200 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 13,100 | 31,800 | 40,300 | 17,400 | | Earnings Before Interest And Taxes | 682,500 | 486,300 | 235,400 | 520,600 | | Interest Expense | 1,300 |
-
|
-
|
-
| | Income Before Tax | 681,200 | 486,300 | 235,400 | 520,600 | | Income Tax Expense | 168,200 | 144,900 | (8,400) | 129,600 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 513,000 | 341,400 | 243,800 | 391,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 513,000 | 341,400 | 243,800 | 391,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $513,000 | $341,400 | $243,800 | $391,000 |
|
0.96% Nasdaq 
Income Statement
